Ab externo implantation of the MicroShunt, a poly(styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review

Sadruddin O., Pinchuk L., Angeles R., Palmberg P.

2019
Eye and vision

View publication

Therapeutic Area

Glaucoma
Technology

Other

Affiliations

Santen Inc, Emeryville, CA USA; InnFocus Inc., a Santen Company, Miami, FL USA; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine,
Miami, FL USA

Related Publications

Long-term safety and efficacy of sepetaprost, with or without timolol, in patients with open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J2 study

Inatani M., Tone Y., Ikeda T., Angeles R.

Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study

Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.

Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.

View all Glaucoma publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022